Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis

Bestvina, Christine M.; Whisenant, Jennifer G.; Torri, Valter; Cortellini, Alessio; Wakelee, Heather A.; Peters, Solange; Roca, Elisa; Toma, Alessandro De; Hirsch, Fred R.; Mamdani, Hirva; Halmos, Balázs; Arrieta, Óscar; Métivier, Anne-Cécile; Fidler, Mary J.; Rogado, Jacobo; Presley, Carolyn J.; Mascaux, Céline; Genova, Carlo; Blaquier, Juan Bautista; Addeo, Alfredo; Finocchiaro, Giovanna; Hina, Kazuyoshi; Morgillo, Floriana; Bar, Jair; Aujayeb, Avinash; Mountzios, Giannis; Scotti, Vieri; Grosso, Federica; Geraedts, Erica J; Zhumagaliyeva, Ardak; Horn, Leora; Garassino, Marina Chiara; Baena, Javier

doi:10.1016/j.jtocrr.2022.100335

Cited by 14 publications

(16 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A multicentric analysis of clinical outcomes among the omicron infected patients revealed that the vaccinated persons and people who received booster doses are protected against hospitalization and death (OR 0.30, CI 0.15-0.57, p=0.0003) [ 23 ]. A prospective cohort study from the United Kingdom that observed clinical outcomes among the long-term care facility people has noted reduced severity of infections (hospitalizations (0·64, 95% CI 0·41-1·00; p=0·051) and mortality (aHR 0·68, 0·44-1·04; p=0·076) caused by the omicron as compared to the previous variants [ 24 ].…”

Section: Discussionmentioning

confidence: 99%

Assessment of SARS-CoV-2 Infected Patients and Their Clinical Outcomes During the Third Wave in India: A Single-Center Observational Study

Shahapur¹,

Shahapur²,

Kandi³

et al. 2022

Cureus

View full text Add to dashboard Cite

BackgroundThe severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) that emerged from the Chinese mainland has spread throughout the world affecting the normal lives of the people. Both developed and developing nations have been equally affected and coronavirus disease-19 (COVID-19) resulted in the death of millions of people worldwide. The virus is undergoing mutations and is evolving into variants that are responsible for wave after wave. This study was carried out to assess the clinical outcomes of people infected with the novel virus during the third wave of the COVID-19 pandemic in India. MethodsThe study was carried out between November 2021 and January 2022 and included 100 consecutive patients attending the hospital attached to the BLDE (Deemed to

show abstract

Section: Discussionmentioning

confidence: 99%

Assessment of SARS-CoV-2 Infected Patients and Their Clinical Outcomes During the Third Wave in India: A Single-Center Observational Study

Shahapur¹,

Shahapur²,

Kandi³

et al. 2022

Cureus

View full text Add to dashboard Cite

show abstract

“…This could be explained by the wide range of centres from many countries with different exposure to the pandemic. COVID-19 vaccination showed a protective effect on hospitalisation and death (OR 0.30, 95% CI 0.15–0.57, p=0.0003) [ 9 ].…”

Section: Group 81mentioning

confidence: 99%

ERS International Congress 2022: highlights from the Thoracic Surgery and Lung Transplantation Assembly

et al. 2023

View full text Add to dashboard Cite

The thoracic surgery and lung transplantation assembly (Assembly 8) of the European Respiratory Society (ERS) is delighted to present the highlights from the 2022 ERS International Congress that took place in a hybrid version in Barcelona, Spain. We have selected the four main sessions that discussed recent advances across a wide range of topics including the effects of COVID-19 on thoracic surgery and the challenges regarding lung transplantation in connective tissue diseases and common variable immunodeficiency (CVID). The sessions are summarised by early career members in close collaboration with the assembly faculty. We aim to provide the reader with an update and enhanced insight into the highlights of the conference in the fields of thoracic surgery and lung transplantation.

show abstract

“… 12 Furthermore, protracted courses of COVID-19 are often observed in these patients leading to treatment interruptions and thus potentially endangering the success of oncologic therapies. 13 Adequate prophylaxis and treatment strategies of COVID-19 are therefore of the utmost importance in this patient population.…”

Section: Introductionmentioning

confidence: 99%

AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants

Giesen¹,

Busch²,

Schalk³

et al. 2023

European Journal of Cancer

View full text Add to dashboard Cite

Coronavirus Disease 2019 Outcomes, Patient Vaccination Status, and Cancer-Related Delays During the Omicron Wave: A Brief Report From the TERAVOLT Analysis

Cited by 14 publications

References 11 publications

Assessment of SARS-CoV-2 Infected Patients and Their Clinical Outcomes During the Third Wave in India: A Single-Center Observational Study

Assessment of SARS-CoV-2 Infected Patients and Their Clinical Outcomes During the Third Wave in India: A Single-Center Observational Study

ERS International Congress 2022: highlights from the Thoracic Surgery and Lung Transplantation Assembly

AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants

Contact Info

Product

Resources

About